Bicycle Therapeutics Announces Clinical Milestone & Expands Collaboration with ThromboGenics

Bicycle Therapeutics Announces Clinical Milestone & Expands Collaboration with ThromboGenics

May 25, 2018 Phase 1 clinical study initiated evaluating THR-149 in diabetic macular edema (DME) Alliance extended to develop additional¬†Bicycles¬†for ophthalmology CAMBRIDGE, England & BOSTON–(BUSINESS WIRE)–Bicycle Therapeutics, a biotechnology company pioneering a new class of therapeutics based on its proprietary